Domain Therapeutics SA announced today that Domain Therapeutics grants Prexton Therapeutics an exclusive option to license and develop metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting ...
Tags: Domain Therapeutics SA, chemical, drugs
Northrop Grumman has won bioinformatics integration support contract (BISC) worth $30m from the National Institutes of Health (NIH) for information technology and bioinformatics technology services. NIH will leverage the technology in ...
Tags: Northrop Grumman, BISC, immunology, immune-mediated diseases
Janssen Biotech has signed a license agreement with Astellas Pharma for the worldwide development and commercialization of ASP015K, except in Japan. Astellas will continue development and commercialization of ASP015K in Japan. ASP015K, ...
Tags: Janssen Biotech, Astellas Pharma, license agreement, ASP015K